The patient is under evaluation for surgical intervention For suspected developmental delay, epilepsy Continued below Yes and neonatal diabetes (DEND) syndrome: Continued from above The patient has developmental delay, any 81403 epilepsy and neonatal diabetes provider, Molecular Pathology except with The confirmation of the diagnosis and the Procedure, 4 TAR treatment strategy is contingent on the override test result KIR (killer cell immunoglobulin-like receptor for hematopoietic stem cell transplantation): The patient has diagnosis of acute myeloid leukemia, and The test is used for donor search process for patients considering hematopoietic stem cell transplantation Known family variant not otherwise specified, for gene listed in Molecular Pathology Procedure Levels 1 - 3 or identified during a genomic sequencing procedure (GSP), DNA sequence analysis, each variant exon: Documentation of the specific gene listed in Molecular Pathology Procedure Levels 1 - 3 or GSP for which further analysis is being requested MICA (solid organ transplantation): The patient is undergoing evaluation for kidney transplantation, or The patient is post kidney transplantation
Continued below Continued from above 81403 Molecular Pathology Procedure, 4 Yes The patient is under evaluation for surgical intervention For suspected developmental delay, epilepsy and neonatal diabetes (DEND) syndrome: The patient has developmental delay, epilepsy and neonatal diabetes The confirmation of the diagnosis and the treatment strategy is contingent on the test result KIR (killer cell immunoglobulin-like receptor for hematopoietic stem cell transplantation): The patient has diagnosis of acute myeloid leukemia, and The test is used for donor search process for patients considering hematopoietic stem cell transplantation Known family variant not otherwise specified, for gene listed in Molecular Pathology Procedure Levels 1 - 3 or identified during a genomic sequencing procedure (GSP), DNA sequence analysis, each variant exon: Documentation of the specific gene listed in Molecular Pathology Procedure Levels 1 - 3 or GSP for which further analysis is being requested MICA (solid organ transplantation): The patient is undergoing evaluation for kidney transplantation, or The patient is post kidney transplantation any provider, except with TAR override